XML 59 R52.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information - Summary of Operating Result Information for Each Reportable Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue        
Revenue $ 19,906 $ 20,157 $ 56,978 $ 60,792
Cost of goods sold        
Cost of goods sold 2,709 3,250 8,100 9,068
Gross profit        
Gross profit 17,197 16,907 48,878 51,724
Operating expenses (25,102) (28,136) (82,308) (90,327)
Investment income 965 1,454 3,139 4,628
Interest expense (1,306) (1,151) (3,853) (3,501)
Loss on debt extinguishment 0 0 0 (1,962)
Other income (expense), net (2) 26 (118) (25)
Loss before income taxes (8,248) (10,900) (34,262) (39,463)
Surgical Glaucoma        
Revenue        
Revenue 19,718 18,632 56,063 57,132
Cost of goods sold        
Cost of goods sold 2,592 2,453 7,662 7,084
Gross profit        
Gross profit 17,126 16,179 48,401 50,048
Dry Eye        
Revenue        
Revenue 188 1,525 915 3,660
Cost of goods sold        
Cost of goods sold 117 797 438 1,984
Gross profit        
Gross profit $ 71 $ 728 $ 477 $ 1,676